Answers are grounded in this paper and cite their sources.
There is ever-increasing anticipation for the potential of mass drug administration of endectocides (also known as systemic insecticides) to reduce malaria transmission, with ivermectin emerging as the most likely first-in-class endectocide.1 More than half of the 46 papers published on this subject in the past decade appeared in the past 2 years. 23 projects are registered in the MESA Track database, of which seven are active today; and, more importantly, trial mapping by the Malaria Ivermectin Roadmap2 shows that abundant new evidence on the topic will be available by 2020.
No takes yet. Share an insight, caveat, or question.
Chaccour et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: